Q3 2017 EPS Estimates for Humana Inc. (HUM) Lifted by Leerink Swann
Humana Inc. (NYSE:HUM) – Stock analysts at Leerink Swann boosted their Q3 2017 earnings per share (EPS) estimates for shares of Humana in a note issued to investors on Thursday. Leerink Swann analyst A. Gupte now anticipates that the insurance provider will post earnings per share of $3.24 for the quarter, up from their prior estimate of $3.18. Leerink Swann has a “Outperform” rating and a $265.00 price objective on the stock. Leerink Swann also issued estimates for Humana’s Q4 2017 earnings at $2.12 EPS, FY2017 earnings at $11.60 EPS, FY2019 earnings at $14.25 EPS and FY2020 earnings at $16.60 EPS.
A number of other equities research analysts have also recently weighed in on HUM. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $237.00 price objective on the stock in a report on Tuesday, April 18th. Jefferies Group LLC cut shares of Humana from a “buy” rating to a “hold” rating and cut their price objective for the stock from $237.00 to $221.00 in a report on Friday, April 21st. Cowen and Company restated an “outperform” rating and issued a $230.00 price objective on shares of Humana in a report on Tuesday, April 25th. Evercore ISI restated an “outperform” rating and issued a $240.00 price objective on shares of Humana in a report on Tuesday, April 25th. Finally, Cantor Fitzgerald upped their price objective on shares of Humana from $190.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, April 26th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $241.65.
Humana (HUM) opened at 245.93 on Monday. Humana has a 12 month low of $163.50 and a 12 month high of $251.79. The company has a 50-day moving average of $236.19 and a 200 day moving average of $220.68. The company has a market cap of $35.54 billion, a PE ratio of 20.23 and a beta of 0.91.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The business had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter last year, the firm earned $2.30 EPS.
In related news, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction that occurred on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the transaction, the vice president now owns 8,150 shares in the company, valued at approximately $1,890,474. The disclosure for this sale can be found here. 0.80% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. increased its position in shares of Humana by 2,281.7% in the first quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after buying an additional 11,867,056 shares during the period. Vanguard Group Inc. increased its position in shares of Humana by 3.6% in the first quarter. Vanguard Group Inc. now owns 9,734,767 shares of the insurance provider’s stock worth $2,006,725,000 after buying an additional 339,620 shares during the period. State Street Corp increased its position in shares of Humana by 1.4% in the first quarter. State Street Corp now owns 6,274,811 shares of the insurance provider’s stock worth $1,293,487,000 after buying an additional 84,716 shares during the period. FMR LLC increased its position in shares of Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock worth $1,041,184,000 after buying an additional 1,851,197 shares during the period. Finally, Renaissance Technologies LLC increased its position in shares of Humana by 84.3% in the first quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock worth $554,867,000 after buying an additional 1,231,400 shares during the period. Institutional investors own 99.62% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.